Vita Foods Asia 2025: Postbiotics Industry Sector 2025-2032 | Revenue Projections - Ab-Biotics, 1Q Health GmbH, Wecare Probiotics Co., Ltd, Novonesis, PROBIOTICAL S.p.A.

DataM Intelligence has published a new research report on "postbiotics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

In 2024, South Asia's Leucine Rich Bio celebrates its #HappyGutMission, promoting gut health awareness and personalized wellness insights. Rising postbiotic use in infant, elderly, and pet nutrition further expands the market.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/postbiotics-market?kb

In 2024, Gaia Herbs is focusing on gut and immune health with its "full spectrum postbiotics" in Ginger-Turmeric, Sauerkraut, Ginger-Beet, and Kimchi capsules. Meanwhile, Kerry introduced Plenibiotic, a rice-based postbiotic from Lactobacillus casei subsp. 327, clinically shown to support digestive and skin health. These innovations accelerate market adoption, strengthen consumer trust through scientific validation, and expand postbiotics' use in functional foods, beverages, and supplements worldwide.

Kerry Group's EpiCor, a yeast-derived postbiotic, is featured in functional foods like cereals and snack bars across the U.S. and Europe, offering immune support with long shelf life and no refrigeration. With rising demand for clean-label, vegan, and plant-based products, postbiotics serve as a natural, non-GMO, allergen-friendly way to enhance functionality without live cultures. In Europe, plant-based yogurts fortified with heat-inactivated Lactobacillus postbiotics are becoming increasingly popular.

Key Players:

MCLS Europe B.V., DSM-Firmenich AG, Cargill Inc, Novozymes OneHealth, ILDONG PHARMACEUTICAL CO., LTD, ADM, Shanghai Novanat Co., Ltd, Sirius Pet Biologics Pte Ltd, POSTBIOTICA S.R.L., Lactobio A/S and among others.

Key Development:

In 2025, ADM partnered with Japan's Asahi Group to launch a new postbiotic ingredient aimed at supporting sleep, stress relief, and mood. Derived from Lactobacillus gasseri and supported by eight clinical trials, the ingredient demonstrates validated functional benefits.

Growth Forecast Projected:

The Global postbiotics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global postbiotics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=postbiotics-market

Key Segments:

By Form: (Powder, Capsules, Tablets, Liquids, Others)

By Application: (Personal Care and Cosmetics, Food and Beverages, Animal Feed, Pharmaceuticals, Others)

By Distribution Channel: (Online Retail, Supermarkets/Hypermarkets, Drug Stores, Retail Stores, Others)

Regional Analysis for Market:

Asia-Pacific (APAC) leads the postbiotics market, supported by its rich tradition of fermented foods and increasing health awareness.

In 2024, investment in Asia's biotechnology startups-spanning food, agriculture, bioenergy, and biomaterials-has surged, raising nearly $3.5 billion over the past three years, a 140% increase from the previous period. With 55% of the world's population (around 4.4 billion) living in Asia in 2022, including 649 million aged 60+, expected to double to 1.3 billion by 2050, APAC leads the postbiotics market. This dominance is driven by traditional dietary practices, growing health awareness, strong biotech investments, and innovation-focused manufacturing, positioning the region as a key hub for postbiotic consumption and production.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among postbiotics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze postbiotics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/postbiotics-market?kb

FAQ's

Q1: What is the current size of the postbiotics Market?

A: The postbiotics Market stood at US$ 125.77 million in 2024 and is set to experience remarkable growth, reaching US$ 261.86 million by 2032

Q2: How fast is the postbiotics Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 9.60% from 2025 to 2032

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.